65 related articles for article (PubMed ID: 17971761)
21. Genetic and epigenetic alterations of the APC gene in malignant melanoma.
Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P
Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491
[TBL] [Abstract][Full Text] [Related]
22. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.
Rothhammer T; Poser I; Soncin F; Bataille F; Moser M; Bosserhoff AK
Cancer Res; 2005 Jan; 65(2):448-56. PubMed ID: 15695386
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.
Braeuer RR; Zigler M; Villares GJ; Dobroff AS; Bar-Eli M
Semin Cancer Biol; 2011 Apr; 21(2):83-8. PubMed ID: 21147226
[TBL] [Abstract][Full Text] [Related]
24. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
25. Impact of LIF (leukemia inhibitory factor) expression in malignant melanoma.
Kuphal S; Wallner S; Bosserhoff AK
Exp Mol Pathol; 2013 Oct; 95(2):156-65. PubMed ID: 23831429
[TBL] [Abstract][Full Text] [Related]
26. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma.
Strub T; Giuliano S; Ye T; Bonet C; Keime C; Kobi D; Le Gras S; Cormont M; Ballotti R; Bertolotto C; Davidson I
Oncogene; 2011 May; 30(20):2319-32. PubMed ID: 21258399
[TBL] [Abstract][Full Text] [Related]
27. Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth.
Xu M; Chen X; Chen N; Nie L; Li X; Li Q; Zeng H; Zhou Q
Am J Pathol; 2013 Jan; 182(1):84-95. PubMed ID: 23159945
[TBL] [Abstract][Full Text] [Related]
28. AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation.
Madireddi MT; Dent P; Fisher PB
J Cell Physiol; 2000 Oct; 185(1):36-46. PubMed ID: 10942517
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA regulation of melanoma progression.
Bonazzi VF; Stark MS; Hayward NK
Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
[TBL] [Abstract][Full Text] [Related]
30. Dynamic expression of Lef/Tcf family members and beta-catenin during chick gastrulation, neurulation, and early limb development.
Schmidt M; Patterson M; Farrell E; Münsterberg A
Dev Dyn; 2004 Mar; 229(3):703-7. PubMed ID: 14991726
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.
Kappelmann M; Kuphal S; Meister G; Vardimon L; Bosserhoff AK
Oncogene; 2013 Jun; 32(24):2984-91. PubMed ID: 22797068
[TBL] [Abstract][Full Text] [Related]
32. Role of microphthalmia transcription factor (Mitf) in melanoma differentiation.
Lekmine F; Chang CK; Sethakorn N; Das Gupta TK; Salti GI
Biochem Biophys Res Commun; 2007 Mar; 354(3):830-5. PubMed ID: 17266927
[TBL] [Abstract][Full Text] [Related]
33. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
Vachtenheim J; Ondrusová L; Borovanský J
Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088
[TBL] [Abstract][Full Text] [Related]
34. Role of microphthalmia transcription factor in regulation of melanocyte differentiation marker TRP-1.
Fang D; Setaluri V
Biochem Biophys Res Commun; 1999 Mar; 256(3):657-63. PubMed ID: 10080955
[TBL] [Abstract][Full Text] [Related]
35. Identification of AP-2-regulated genes by macroarray profiling of gene expression in human A375P melanoma.
Suyama E; Minoshima H; Kawasaki H; Taira K
Nucleic Acids Res Suppl; 2002; (2):247-8. PubMed ID: 12903198
[TBL] [Abstract][Full Text] [Related]
36. Get with the Program! Stemness and Reprogramming in Melanoma Metastasis.
Faião-Flores F; Smalley KSM
J Invest Dermatol; 2018 Jan; 138(1):10-13. PubMed ID: 29273143
[TBL] [Abstract][Full Text] [Related]
37. [Melanoma research in Hungary: promising results in a previously orphan tumor].
Balázs M; Vízkeleti L; Ecsedi S; Ádány R; Rásó E; Hegedûs B; Ladányi A; Tóvári J; Tímár J
Magy Onkol; 2015 Dec; 59(4):275-81. PubMed ID: 26665186
[TBL] [Abstract][Full Text] [Related]
38. Transcription-factor-modulating agents: precision and selectivity in drug design.
Papavassiliou AG
Mol Med Today; 1998 Aug; 4(8):358-66. PubMed ID: 9755455
[TBL] [Abstract][Full Text] [Related]
39. Genetic aspects of malignant melanoma.
CAWLEY EP; KRUSE WT; PINKUS HK
AMA Arch Derm Syphilol; 1952 Apr; 65(4):440-50. PubMed ID: 14902112
[No Abstract] [Full Text] [Related]
40. [Transcription factors in the development and progression of melanoma].
Lesiak K; Sztiller-Sikorska M; Czyz M
Postepy Hig Med Dosw (Online); 2007 Oct; 61():576-95. PubMed ID: 17971761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
